Difference between MCTD overlap syndrome and UCTD

Sharing is caring!

What is the difference between MCTD overlap syndrome and UCTD?

• MCTD: first described by Sharp et al. in 1972, this is a very specific overlap syndrome characterized by a combination of manifestations similar to those seen in SLE, SSc, and inflammatory myopathy. Some patients have a severe erosive arthritis with Jaccoud’s deformity. The autoantibody pattern is a high-titer, speckled ANA, and U1-RNP (high titer). These patients lack other specific autoantibodies such as anti-Sm, anti-Sjögren’s syndrome antigen B (SS-B), anti-ds DNA, and anti-centromere. MCTD is 15 times more common in women than in men. The mean age at diagnosis is 37 years, with a range of 4 to 80 years. There is no apparent racial or ethnic predisposition.

• Overlap syndrome: these patients have features of more than one of the six classic systemic autoimmune rheumatic diseases (SLE, SSc, polymyositis [PM], dermatomyositis, rheumatoid arthritis [RA], and SS). Some overlap syndromes like MCTD and certain myositis overlap syndromes have specific autoantibody associations.

• UCTD: refers to a situation in which a patient has some of the clinical features of one or more of the systemic autoimmune rheumatic diseases in the setting of a positive ANA, but do not meet criteria for a more specific diagnosis. About 25% of patients referred to a rheumatologist may present as such. Over time, a similar percentage will develop additional clinical features that will allow a specific disease diagnosis, whereas the majority will remain undifferentiated.

Sharing is caring!

You cannot copy content of this page


Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top